MDS clinical diagnostic criteria for Parkinson's disease
Ronald B. Postuma(Montreal Neurological Institute and Hospital), Günther Deuschl(Christian-Albrechts-Universität zu Kiel), Irene Litvan(University of California, San Diego), Christopher G. Goetz(Rush University Medical Center), Charles H. Adler(WinnMed), Bastiaan R. Bloem(Radboud University Nijmegen), Glenda M. Halliday(The University of Sydney), Piu Chan(Capital Medical University), Werner Poewe(Innsbruck Medical University), Wolfgang H. Oertel(Philipps University of Marburg), José Á. Obeso(Instituto de Salud Carlos III), Thomas Gasser(Hertie Institute for Clinical Brain Research), Matthew Stern(Penn Center for AIDS Research), C. Warren Olanow(Icahn School of Medicine at Mount Sinai), Kenneth Marek(University of Pennsylvania), Anthony E. Lang(University of Toronto), Bruno Dubois(Université de Lille), Daniela Berg(Christian-Albrechts-Universität zu Kiel)
Cited by 7,441
Related Papers
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
The Emerging Evidence of the Parkinson Pandemic
|Journal of Parkinson s Disease|2018|1.9k